ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Student involvement in characterizing the landscape of the new discipline of tissue engineering pathology: A brave new world in pathology

4th International Conference and Exhibition on Pathology

Korey Fung1, Kim Solez1, Anson Dong1, Rongjia Liu1, Sina Marzoughi1, Patricia Bacus1, Punit Virk1 and Lynn Cornell2

ScientificTracks Abstracts-Workshop: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.016

Abstract
The course on Technology and the Future of Medicine at the University of Alberta attracts a small subset of University students from 5-14 per term. About half of the students continue on in some way with the futuristic subject matter of the course after the course ends. Both technology advocates and technology skeptics teach in the course so students are exposed to a wide range of views. Regenerative medicine and stem cell generation of organs has been one of the themes of the course since the very first focus group that helped laid its foundations in May 2011. It was natural then when the opportunity arose to define the new discipline of tissue engineering pathology to involve the students in this effort. The idea of creating a new discipline with this name was first suggested by Dr. Solez at the 2011 Banff Transplant Pathology meeting in Paris. In November 2014 six students from the course began discussing the creation of a classification for the new discipline and in March 2015 these six University of Alberta students submitted abstracts for the Pathology-2015 meeting in New Orleans on the subject of tissue engineering pathology and related subjects. Many of these abstracts were for single author youth research forum presentations. The meeting July13-15, 2015 will be the first broad based discussion of this new pathology discipline and will mark the first time a new discipline in pathology has had such a distinctive and clearly defined start.
Biography
Kim Solez, MD, FRCPC, Professor of Pathology at the University of Alberta, and President and CEO of Transpath Inc., is one of the worldâ??s foremost kidney pathologists. He is the father of the Banff classification that sets standards worldwide for how biopsies from kidney and other solid organ transplants are interpreted, and started the post-earthquake disaster relief task force of the International Society of Nephrology. He is a popular blogger on internetevolution.com, and directs NKF cyber Nephrology, a joint venture of the National Kidney Foundation (U.S.) and the University of Alberta. He has also created many educational videos for the Lifeboat Foundation.
Top